Skip to main content
. 2017 Sep 20;13(9):e1006629. doi: 10.1371/journal.ppat.1006629

Fig 1. Rationale for hypothesizing preferential T-cell recognition of early versus late HIV gene products in ART-treated individuals.

Fig 1